Quo Vadis Urogynecology 2020 - Innovative Treatment Concepts for Urinary Incontinence and Pelvic Organ Prolapse
- PMID: 33574622
- PMCID: PMC7870286
- DOI: 10.1055/a-1302-7803
Quo Vadis Urogynecology 2020 - Innovative Treatment Concepts for Urinary Incontinence and Pelvic Organ Prolapse
Abstract
The current treatment for urinary incontinence and pelvic organ prolapse includes a wide range of innovative options for conservative and surgical therapies. Initial treatment for pelvic floor dysfunction consists of individualized topical estrogen therapy and professional training in passive and active pelvic floor exercises with biofeedback, vibration plates, and a number of vaginal devices. The method of choice for the surgical repair of stress urinary incontinence consists of placement of a suburethral sling. A number of different methods are available for the surgical treatment of pelvic organ prolapse using either a vaginal or an abdominal/endoscopic approach and autologous tissue or alloplastic materials for reconstruction. This makes it possible to achieve optimal reconstruction both in younger women, many of them affected by postpartum trauma, and in older women later in their lives. Treatment includes assessing the patient's state of health and anesthetic risk profile. It is important to determine a realistically achievable patient preference after explaining the individualized concept and presenting the alternative surgical options.
Keywords: pelvic organ prolapse; sacrocolpopexy; stress incontinence; suburethral sling; vaginal uterine fixation.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Conflict of interest statement
Conflict of Interest/Interessenkonflikt Received study funding and speakerʼs fees from Promedon./Studienunterstützung und Vortragshonorare Fa. Promedon.
References
-
- Crean-Tate K K, Faubion S S, Pederson H J. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. Am J Obstet Gynecol. 2020;222:103–113. - PubMed
-
- Ford A A, Taylor V, Ogah J. Midurethral slings for treatment of stress urinary incontinence review. Neurourol Urodyn. 2019;38:S70–S75. - PubMed
-
- Leone Roberti Maggiore U, Finazzi Agrò E, Soligo M. Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2017;28:1119–1130. - PubMed
-
- Kim A, Kim M S, Park Y J. Clinical outcome of single-incision slings, excluding TVT-Secur, vs. standard slings in the surgical management of stress incontinence: an updated systematic review and meta-analysis. BJU Int. 2019;123:566–584. - PubMed
-
- Huebner M, Tunn R, Reisenauer C. Surgical procedures for the treatment of stress urinary incontinence (SUI) in the light of the updated FDA-warning and its effects on practise patterns in Germany between 2010 and 2018. Abstract 63. EUGA 2020 Interactive Meeting 11. – 12.12.2020 Dublin - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources